glp-1 rheumatoid arthritis Medications and Arthritis: What the 2025 Research Actually Shows Association between autoimmune diseases and

pharmacies Injection supplies (syringes, needles) for injectable formats Ongoing medical support through licensed providers How It Works Complete a health intake quiz online (about 2-5 minutes) A licensed medical provider reviews your information and determines eligibility If approved, you may receive a prescription directly or be scheduled for a video consultation at no extra cost Your prescription goes to a licensed compounding pharmacy and ships overnight Ongoing refills require monthly eligibility confirmation

Were it not for their efforts we might not have this unprecedented treatment for obesity, which has now unlocked many other potential clinical applications

In the SURMOUNT-1 trial, tirzepatide produced average weight reductions of 15.0%, 19.5%, and 20.9% at studied doses compared with 3.1% with placebo over 72 weeks

Mollan S, Hemmings K, Herd CP, Denton A, Williamson S, Sinclair AJ

Historical Context The development of GLP-1 receptor agonists, which are synthetic versions of the hormone, has transformed the landscape of weight management and diabetes treatment

However, medication alone is rarely the complete answer